| scholarly article | Q13442814 |
| P50 | author | Laura A Marlow | Q56600296 |
| P2093 | author name string | Edith A Perez | |
| John A Copland | |||
| Simon J Cooper | |||
| Han W Tun | |||
| Gerardo Colon-Otero | |||
| Stefan K Grebe | |||
| Christina A von Roemeling | |||
| Michael E Menefee | |||
| Kylie H Kang | |||
| P2860 | cites work | Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation | Q21195230 |
| Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer | Q21245721 | ||
| SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway | Q24303537 | ||
| Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma | Q24336272 | ||
| Wnt signal transduction pathways | Q24641814 | ||
| Reactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growth | Q24651313 | ||
| Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
| Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/beta-catenin signalling | Q28141530 | ||
| Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma | Q28240852 | ||
| Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer | Q28251800 | ||
| Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer | Q28260824 | ||
| Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer | Q28291617 | ||
| Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis | Q28294866 | ||
| Gene silencing in cancer in association with promoter hypermethylation | Q29617274 | ||
| Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms | Q33341474 | ||
| Inhibitors of histone deacetylase as new anticancer agents | Q34372944 | ||
| The changing natural history of renal cell carcinoma | Q34391104 | ||
| Detailed Molecular Fingerprinting of Four New Anaplastic Thyroid Carcinoma Cell Lines and Their Use for Verification of RhoB as a Molecular Therapeutic Target | Q34395370 | ||
| Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation | Q34542069 | ||
| Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis | Q34763742 | ||
| 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy | Q34770609 | ||
| Signaling pathways in renal cell carcinoma | Q34978827 | ||
| Triple negative breast cancer: unmet medical needs | Q35630269 | ||
| Novel treatments for metastatic renal cell carcinoma | Q36175671 | ||
| Wnt signaling through canonical and non-canonical pathways: recent progress | Q36194509 | ||
| FK228 (depsipeptide): a HDAC inhibitor with pleiotropic antitumor activities | Q36376849 | ||
| Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer | Q36510089 | ||
| Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells | Q36759572 | ||
| Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease | Q37102953 | ||
| WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth | Q37277156 | ||
| Treatment of triple-negative metastatic breast cancer: toward individualized targeted treatments or chemosensitization? | Q37799942 | ||
| Loss of type III transforming growth factor-beta receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma | Q38345995 | ||
| Deoxycytidine kinase is overexpressed in poor outcome breast cancer and determines responsiveness to nucleoside analogs | Q39564485 | ||
| Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer | Q39722426 | ||
| Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma | Q39739609 | ||
| Methylation-associated silencing of SFRP1 in renal cell carcinoma. | Q39925650 | ||
| Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models | Q39970361 | ||
| DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines | Q39992913 | ||
| DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B. | Q40054309 | ||
| Novel high-affinity PPARgamma agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1. | Q40343222 | ||
| Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers. | Q40506716 | ||
| 5-aza-2'-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation. | Q40599594 | ||
| Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines | Q41072124 | ||
| Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968, on Ha-ras transformed NIH3T3 cells | Q41446518 | ||
| Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas | Q42519640 | ||
| DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors. | Q43540230 | ||
| Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. | Q46696080 | ||
| Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma. | Q53335862 | ||
| Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma. | Q53606125 | ||
| The EORTC Early Clinical Trials Cooperative Group experience with 5-aza-2'-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas | Q69018368 | ||
| P4510 | describes a project that uses | KIJ265T | Q54899922 |
| P433 | issue | 10 | |
| P921 | main subject | cell line | Q21014462 |
| P304 | page(s) | 2105-2115 | |
| P577 | publication date | 2012-07-23 | |
| P1433 | published in | Molecular Cancer Therapeutics | Q2363144 |
| P1476 | title | Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers | |
| P478 | volume | 11 |
| Q49163340 | Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy |
| Q59353428 | Combinatorial Antitumor Activity of Oxaliplatin with Epigenetic Modifying Agents, 5-Aza-CdR and FK228, in Human Gastric Cancer Cells |
| Q35000789 | Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer |
| Q59791142 | Development of Fangjiomics for Systems Elucidation of Synergistic Mechanism Underlying Combination Therapy |
| Q34273997 | Differential expression of centrosome regulators in Her2+ breast cancer cells versus non-tumorigenic MCF10A cells |
| Q38233472 | Epigenetic reprogramming in breast cancer: from new targets to new therapies |
| Q38121995 | Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylases. |
| Q89781850 | Epigenetics of SFRP1: The Dual Roles in Human Cancers |
| Q41574276 | Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma |
| Q36200052 | Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer |
| Q38979602 | Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration. |
| Q36896100 | Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells |
| Q64069266 | MiR-1180 from bone marrow MSCs promotes cell proliferation and glycolysis in ovarian cancer cells via SFRP1/Wnt pathway |
| Q47994522 | MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway |
| Q92287784 | Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma |
| Q28277902 | SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer |
| Q28115695 | Secreted Frizzled-related protein potentiation versus inhibition of Wnt3a/β-catenin signaling |
| Q37728993 | Secreted frizzled related protein 1 modulates taxane resistance of human lung adenocarcinoma |
| Q48091254 | Secreted frizzled-related protein 1 (SFRP1) gene methylation changes in the human lung adenocarcinoma cells treated with L-securinine |
| Q36818377 | Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma |
| Q35204798 | Study of SFRP1 and SFRP2 methylation status in patients with de novo Acute Myeloblastic Leukemia |
| Q36634661 | Tear levels of SFRP1 are significantly reduced in keratoconus patients |
| Q30978083 | The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set. |
| Q33768390 | The effects of diet induced obesity on breast cancer associated pathways in mice deficient in SFRP1. |
| Q37061554 | The future of epigenetic therapy in solid tumours--lessons from the past. |
| Q48136812 | Therapeutic effects of histone deacetylase inhibitors on kidney disease. |
| Q37484160 | Tumor-specific hypermethylation of epigenetic biomarkers, including SFRP1, predicts for poorer survival in patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project |
| Q54408874 | Tumour supressor secreted frizzled related protein 1 regulates p53-mediated apoptosis. |
| Q47818549 | WNT signalling in prostate cancer. |
| Q49087470 | Wnt inhibition is dysregulated in gliomas and its re-establishment inhibits proliferation and tumor sphere formation |
| Q47152122 | miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer |
| Q54899922 | KIJ265T | described by source | P1343 |
Search more.